New Rochelle, NY, May 3, 2017-Researchers have shown that following a stroke-induced ischemic injury to the human brain, stem cells are produced that have the potential to differentiate and mature to form neurons that can help repair the damage to the brain. The new clinical study that provides direct evidence of ischemia-induced stem cells (iSCs) in brain tissue removed during treatment of post-stroke patients is published in Stem Cells and Development, a peer-reviewed journal from Mary Ann Liebert, Inc.," publishers. The article is available open access on the Stem Cells and Development website.
In the article entitled "Identification of Multipotent Stem Cells in Human Brain Tissue Following Stroke," Kotaro Tatebayashi, Yasue Tanaka, Akiko Nakano-Doi, and coauthors from Hyogo College of Medicine, Nishinomiya, Japan, present this first clinical report describing the isolation of iSCs from the post-stroke human brain. The stem cells were situated near blood vessels in areas of the brain containing neurons that had died as a result of stroke-related lack of oxygen. The iSCs expressed multiple stem cell markers, demonstrated high proliferative potential, and were shown to be multipotent in culture with the ability to differentiate into various cell types including neurons.
"This excellently performed demonstration in the human brain confirms previous work in the mouse that showed cerebral ischemia induced multipotent stem cells that were restricted to areas of the brain damaged by stroke," says Editor-in-Chief Graham C. Parker, PhD, The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI.
About the Journal
Stem Cells and Development is an authoritative peer-reviewed journal published 24 times per year in print and online. The Journal is dedicated to communication and objective analysis of developments in the biology, characteristics, and therapeutic utility of stem cells, especially those of the hematopoietic system. A complete table of contents and free sample issue may be viewed on the Stem Cells and Development website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Cellular Reprogramming, Tissue Engineering, and Human Gene Therapy. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc. publishers website.